Health News Archive - April 17, 2009
Dialysis Provider Recognized for Decentralization Model and Transparency EL SEGUNDO, Calif., April 17 /PRNewswire-FirstCall/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, today acknowledged its being named as the first and only FORTUNE 500(R) company and only healthcare company to make the 2009 WorldBlu List of Most Democratic Workplaces(TM) since its inception in 1999.
Mirthful laughter was linked to lower cholesterol and less risk of cardiovascular disease in a study of high-risk diabetic patients, U.S. researchers said. Lee Berk, a psychoneuroimmunologist, of Loma Linda University, and Dr.
Initial drug use can be motivated by curiosity or peer pressure, but in some animals it can result from a stressful event, researchers in Puerto Rico said. Natasha Lugo-Escobar, Nicole Carreras and Annabell C.
Grady to develop world-class Trauma Center and Neurological Intensive Care Unit ATLANTA, April 17 /PRNewswire/ -- The Marcus Foundation today announced a $20 million gift to Grady Health System to improve emergency care to trauma and acute neurological injury victims throughout Georgia.
CLEVELAND, Ohio, April 17 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries. Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in Russia and the rest of the CIS. "We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based interventional training for the CIS medical community and we are looking forward to a mutually beneficial relationship with all the countries covered by the agreement, as well as
A common sexually transmitted disease is not being screened for as often as it should be, according to researchers.
Advocates of safe sex are hoping a less expensive and easier to use female condom will help the global fight against AIDS and other sexually transmitted diseases.
Ninety Percent of People Being Treated for Bipolar Disorder Say They Have Difficulty with Day-To-Day Tasks Due to Depressive Symptoms (1) WASHINGTON, April 17 /PRNewswire/ -- A new national online survey of more than 2,000 people living with bipolar disorder and 500 physicians who treat patients with bipolar disorder identified that the greatest concern among people living with bipolar disorder (73%) is that their symptoms will impact daily life, such as family, relationships, or job.(1) In particular, about 9 in 10 patients (89%) said they have cancelled social engagements because of bipolar depression.(1) In addition, people with bipolar disorder reported that bipolar depressive symptoms affected their ability to manage housework (73%) and run errands (59%).(1) This online survey was commissioned by the National Council for Community Behavioral Healthcare and AstraZeneca to better understand the impact of bipolar depression on people's lives.
TAIAN CITY, China, April 17 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc.
SAN DIEGO, April 17 /PRNewswire/ -- Cylene Pharmaceuticals announced today that it will be presenting new data on recent advances of its small molecule anticancer agents during a symposium and several poster presentations at the American Association for Cancer Research (AACR) annual meeting, to be held on April 18-22 in Denver, Colorado. Cylene scientists will unveil the first public description of CX-4945, a first-in-class oral inhibitor of protein kinase CK2.